Is Misoprostol Equivalent to Oxytocin for Postpartum Hemorrhage?
Chireau, M.V.
Issues in Law and Medicine 30(2): 217-225
2015
ISSN/ISBN: 8756-8160 PMID: 26710381 Document Number: 680982
Document emailed within 1 workday
Related Documents
Quibel, T.; Ghout, I.; Goffinet, Fçois.; Salomon, L.J.; Fort, J.; Javoise, S.; Bussieres, L.; Aegerter, P.; Rozenberg, P. 2016: Active Management of the Third Stage of Labor With a Combination of Oxytocin and Misoprostol to Prevent Postpartum Hemorrhage: A Randomized Controlled Trial Obstetrics and Gynecology 128(4): 805-811Atukunda, E.C.; Siedner, M.J.; Obua, C.; Mugyenyi, G.R.; Twagirumukiza, M.; Agaba, A.G. 2014: Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in Uganda: a double-blind randomized non-inferiority trial Plos Medicine 11(11): E1001752
Haque, N.; Bilkis, L.; Haque, N.; Bari, M.Shafikul.; Haque, S. 2009: Comparative study between rectally administered misoprostol as a prophylaxis versus conventional intramuscular oxytocin in post partum hemorrhage Mymensingh medical journal: MMJ 18(1 Suppl): S40-S44
Smith, J.M.; Dimiti, A.; Dwivedi, V.; Ochieng, I.; Dalaka, M.; Currie, S.; Luka, E.Eremugo.; Rumunu, J.; Orero, S.; Mungia, J.; McKaig, C. 2014: Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 127(2): 183-188
Elati, A.; Weeks, A. 2012: Risk of fever after misoprostol for the prevention of postpartum hemorrhage: a meta-analysis Obstetrics and Gynecology 120(5): 1140-1148
Smith, J.M.; Dimiti, A.; Dwivedi, V.; Ochieng, I.; Dalaka, M.; Currie, S.; Luka, E.Eremugo.; Rumunu, J.; Orero, S.; Mungia, J.; McKaig, C. 2014: Advance distribution of misoprostol for the prevention of postpartum hemorrhage in South Sudan International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 127(2): 183-188
Oladapo, O.T. 2012: Misoprostol for preventing and treating postpartum hemorrhage in the community: a closer look at the evidence International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics 119(2): 105-110
Prata, N.; Bell, S.; Quaiyum, M.Abdul. 2014: Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention Bmc Pregnancy and Childbirth 14: 78
Baruah, M.; Cohn, G.M. 2008: Efficacy of rectal misoprostol as second-line therapy for the treatment of primary postpartum hemorrhage Journal of Reproductive Medicine 53(3): 203-206
Smith, J.Michael.; Baawo, S.Dahn.; Subah, M.; Sirtor-Gbassie, V.; Howe, C.Jabbeh.; Ishola, G.; Tehoungue, B.Z.; Dwivedi, V. 2014: Advance distribution of misoprostol for prevention of postpartum hemorrhage (PPH) at home births in two districts of Liberia Bmc Pregnancy and Childbirth 14: 189
Ejembi, C.; Shittu, O.; Moran, M.; Adiri, F.; Oguntunde, O.; Saadatu, B.; Aku-Akai, L.; Abdul, M.A.; Ajayi, V.; Williams, N.; Prata, N. 2014: Community-level distribution of misoprostol to prevent postpartum hemorrhage at home births in northern Nigeria African Journal of Reproductive Health 18(2): 166-175
Strand, R.T.; Da Silva, F.; Jangsten, E.; Bergström, S. 2005: Postpartum hemorrhage: a prospective, comparative study in Angola using a new disposable device for oxytocin administration Acta Obstetricia et Gynecologica Scandinavica 84(3): 260-265
Spangler, S.A.; Gobezayehu, A.Gebramariam.; Hailemariam, T.Getachew.; Getachew, T.; Sibley, L.M. 2014: Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions Journal of Midwifery and Women's Health 59 Suppl. 1: S83-S90
Tanir, H.M.; Sener, T.; Yildiz, C.; Kaya, M.; Kurt, I. 2008: A prospective randomized trial of labor induction with vaginal controlled-release dinoprostone inserts with or without oxytocin and misoprostol+oxytocin Clinical and Experimental Obstetrics and Gynecology 35(1): 65-68
Patted, S.S.; Goudar, S.S.; Naik, V.A.; Bellad, M.B.; Edlavitch, S.A.; Kodkany, B.S.; Patel, A.; Chakraborty, H.; Derman, R.J.; Geller, S.E. 2009: Side effects of oral misoprostol for the prevention of postpartum hemorrhage: results of a community-based randomised controlled trial in rural India Journal of Maternal-Fetal and Neonatal Medicine: the Official Journal of the European Association of Perinatal Medicine the Federation of Asia and Oceania Perinatal Societies the International Society of Perinatal Obstetricians 22(1): 24-28
Sibley, L.M.; Spangler, S.A.; Barry, D.; Tesfaye, S.; Desta, B.Fekadu.; Gobezayehu, A.Gebremariam. 2014: A regional comparison of distribution strategies and women's awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya regions of Ethiopia Journal of Midwifery and Women's Health 59 Suppl. 1: S73-S82
Pichon-Riviere, Aés.; Glujovsky, Dán.; Garay, O.Ulises.; Augustovski, F.; Ciapponi, A.; Serpa, M.; Althabe, F. 2015: Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis Plos one 10(6): E0129044
Pichon-Riviere, Aés.; Glujovsky, Dán.; Garay, O.Ulises.; Augustovski, F.; Ciapponi, A.; Serpa, M.; Althabe, F. 2015: Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis Plos one 10(6): E0129044
Afolabi, E.O.; Kuti, O.; Orji, E.O.; Ogunniyi, S.O. 2010: Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labour Singapore Medical Journal 51(3): 207-211
Sengoku, R.; Iguchi, Y.; Yaguchi, H.; Sato, H.; Inoue, K. 2005: A case of postpartum cerebral angiopathy with intracranial hemorrhage and subarachnoid hemorrhage immediately after delivery Rinsho Shinkeigaku 45(5): 376-379